Scinai Immunotherapeutics is exploring a novel disease-modifying antibody for pemphigus, while GeoVax Labs is fast-tracking a vaccine for Mpox crisis. Creative Biolabs is pioneering single-domain antibody solutions with high potency against various pathogens, offering valuable insights for oncology, neurology, and infectious disease research. Additionally, they will host a webinar on tumoroid-on-a-chip platform for preclinical testing in oncology research.
